Every company reaches a "make or break" moment - meaning the precise instant in time when it will become a hero or a zero.
I've spent the past few days hunkered down in my office poring over reams of information, and there's no doubt in my mind that's where we are with Ekso Bionics Holdings Ltd. (Nasdaq: EKSO).
The conclusion I've reached may surprise you.
It's an update neither you nor your wallet want to miss.
The Wrong Perspective Could Cost You $1.38 Million
Take a seat... please.
Put your cell phone aside and set down the drink in your hand. I'm going to tell you a story that upsets a lot of investors and I don't want you to spill... or choke.
I've spent 35 years in global markets as a consultant, analyst, and trader, and if there's one thing I've learned from evaluating thousands of companies, it's that every single one has a defining "make or break" moment.
For some, like Facebook Inc. (Nasdaq: FB), it's releasing a disruptive technology that catches the world by storm. For others, like Eastern Airlines, it's the moment they close the doors forever despite having been a trailblazer. And for still more companies, like Monster Beverage Corp. (Nasdaq: MNST) or Amazon.com Inc. (Nasdaq: AMZN), it's the moment where they transition from a startup to a mature player ready to dominate their industry.
It's hard to tell which is which unless you know what to look for and how to frame what you find in terms that make sense. So, let me set the stage.
Think back to 1997.
Enamored by the prospect of making a gazillion dollars overnight because of the media circus surrounding the latest crop of "unicorns" and a bull market that roared to new highs despite overwhelming odds, many investors confused patience with genius.
Twenty years ago, Apple Inc. (Nasdaq: AAPL) - yes, THAT Apple - was on the tail end of 18 consecutive months of financial losses. Its market share was a mere 4% of the PC market, and Club Cupertino was hemorrhaging more than a $1 billion a year.
The stock had fallen more than 50% and the company's balance sheet was so bad that to call it a "loser" would have been an insult to actual losers.
Rival PC maker CEO Michael Dell even went so far as to openly mock Apple, saying that if he ran the place he would "shut it down and give the money back to shareholders."
Obviously, that didn't happen.
Today, Dell is the one who's struggling and Apple is on the verge of becoming the world's most valuable company with a market capitalization approaching $750 billion.
Investors who stayed the course despite overwhelming odds and dim prospects 20 years ago have turned every $10,000 invested then into $1.38 million today.
It's the stuff of legend.
Which is why you've got an important choice to make when it comes to Ekso.
Are You a Speculator or an Investo…
Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter
Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…
About the Author
Keith is a seasoned market analyst and professional trader with more than 37 years of global experience. He is one of very few experts to correctly see both the dot.bomb crisis and the ongoing financial crisis coming ahead of time - and one of even fewer to help millions of investors around the world successfully navigate them both. Forbes hailed him as a "Market Visionary." He is a regular on FOX Business News and Yahoo! Finance, and his observations have been featured in Bloomberg, The Wall Street Journal, WIRED, and MarketWatch. Keith previously led The Money Map Report, Money Map's flagship newsletter, as Chief Investment Strategist, from 20007 to 2020. Keith holds a BS in management and finance from Skidmore College and an MS in international finance (with a focus on Japanese business science) from Chaminade University. He regularly travels the world in search of investment opportunities others don't yet see or understand.
This outfit has been a story stock for me so far. I picked some up before the split and have seen it erode 50% or more since then.Have since bailed but it's on the watchlist.
Hello Mike and thanks for chiming in.
I think your description is apt…a story stock indeed. We've had "show" and now we need "tell" which is, not coincidentally, something every company has to do when it hits the make or break moment.
Best regards and thanks for being part of the Money Morning Family, Keith :-)
What about BNKL? Bionic Laboratories. About $.51. (What is this? bid 0.0500 and ask 80.00 at vol 17781?) Stock has been struggling, also. But has made some significant progress in a similar if not the same field. EKSO shows $3.34 today. Thanks. Love your research and reports.
Thanks for the heads up and, of course, the kind words as well. Let me take a look.
As for the numbers, that's not atypical for a penny-stock trading in illiquid conditions when the bid/ask spread gets wide enough that you can drive a Mack truck through.
Stay tuned and thanks for being part of the Money Morning Family, Keith :-)
Here is a good vote on the technology & what it can do
UPDATE
3/21/17
Ekso GT Named a Finalist in Fast Company’s 2017 World Changing Ideas Awards
http://ir.eksobionics.com/press-releases/detail/605
Barry
Excellent eye, Barry!
Thanks for posting and for sharing.
Best regards and thanks for being part of the Total Wealth Family, Keith :-)
No update since the Q1 earnings results and now with the stock at $1.60??
I ma up 90% in my EKSO stock. This is a gain of $5,268. What is the outlook for this stock going forward?